New York State Psychiatric Institute, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.
Depress Anxiety. 2011 Jul;28(7):589-95. doi: 10.1002/da.20844. Epub 2011 Jun 16.
To explore women's perspectives about the treatment decision-making process for depression during pregnancy and after birth.
One hundred pregnant and postpartum women completed an anonymous web-based surveys regarding treatment decision making for depression.
Survey data reveal that most women in this sample prefer an active collaborative role in treatment decision making for depression. Sixty-five percent of the sample made a decision for treatment of their major depressive disorder, including a decision for no treatment, and 34% reported not having made a decision or feeling unsure about their decision. More than half of the sample preferred combination treatment with medications and counseling (55%) followed by counseling (22%), no treatment (8%), and medications (8%). Overall, respondents in this sample had low levels of decisional conflict (uncertainty) with younger women in the sample reporting higher levels of decisional conflict.
Treatment decision making for depression during the perinatal period is complex. Asking women about their preferences for participation in decision making, their treatment preferences and their decision making needs during the clinical encounter may lead to improved communication, decision making and quality of care.
探讨女性对围产期抑郁症治疗决策过程的看法。
100 名孕妇和产后妇女完成了一份关于抑郁症治疗决策的匿名网络调查。
调查数据显示,该样本中的大多数女性更喜欢在抑郁症的治疗决策中扮演积极的合作角色。65%的样本做出了治疗其重度抑郁症的决定,包括不治疗的决定,34%的样本报告没有做出决定或对自己的决定感到不确定。该样本中有一半以上的人更喜欢药物治疗和咨询相结合(55%),其次是咨询(22%)、不治疗(8%)和药物治疗(8%)。总的来说,该样本中的受访者在决策冲突(不确定性)方面的水平较低,样本中的年轻女性报告的决策冲突水平较高。
围产期抑郁症的治疗决策是复杂的。在临床就诊中询问女性对参与决策的偏好、治疗偏好以及决策需求,可能会改善沟通、决策和护理质量。